Liberate Bio
Seed
AI for genetic medicine
Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.
Location
Boston, Massachusetts, United States
Stage
Seed
Website
LinkedIn
Founders
M
LinkedIn ↗
News & Funding
Similar Startups
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Freenome
Blood test to detect colorectal cancer
Janux Therapeutics
Immunotherapy to fight tumors
Coya Therapeutics
Therapeutics with regulatory T cells
Moderna
mRNA vaccines
Human Longevity
Series B
Early detection for longer life